Similarly, Weydt and colleagues demonstrated that ALS symptomatic carriers presented 10-fold increased levels of p-NfH in comparison to asymptomatic carriers and HC [13]. This evidence concerns the gene NEFH and amyotrophic lateral sclerosis.